Platinum Equity to acquire Energy Distribution Partners after 45 acquisitions and threefold EBITDA growth
Senores Pharmaceuticals (SENORES) targets 3.2bn annual manufacturing units, yet 50% to 70% utilisation raises a bigger question
Aspen Neuroscience (ASPE) prices $140.6m IPO at $15 as Parkinson’s therapy enters pivotal development phase
Read More Pharma Industry News BioCryst Pharmaceuticals gains Japan pediatric approval as ORLADEYO revenue momentum builds Japan expands ORLADEYO to younger children as BioCryst Pharmaceuticals builds its growing global hereditary angioedema franchise. bySoujanya RaviAugust 27, 2026